3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Philadelphia Chromosome
1
Neoplasm, Residual
1
Interventions
Inotuzumab Ozogamicin
1
Idarubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Philadelphia Chromosome
×
Inotuzumab Ozogamicin
×
Clear all
NCT03249870
2023-09-06
EWALL-INO
Versailles Hospital
Phase 2
Unknown
130 enrolled